China Journal of Leprosy and Skin Diseases ›› 2020, Vol. 36 ›› Issue (8): 461-466.doi: 10.12144/zgmfskin202008461

• Original Articles • Previous Articles     Next Articles

Effect of leptin on androgenetic alopecia mouse model

WEN Xuhong, ZHANG Gaofeng, PAN Lun, LIU Guanzhi   

  1. Department of Dermatology, Zigong Fourth People's Hospital, Zigong 643000, China
  • Online:2020-08-15 Published:2020-08-11
  • Contact: LIU Guanzhi, E-mail: 13909006201@139.com

Abstract: Objective:To determine the effect of leptin on androgenetic alopecia. Methods: Forty male C57 mice were randomly assigned. Ten mice were not treated (blank group) and 30 mice were treated with 5 mg/kg·d testosterone propionate injection for 4 weeks to establish the androgenetic alopecia mouse model. Then the mice model were divided into three groups and treated for 4 weeks: model group (testosterone propionate injection), minoxidil group (testosterone propionate injection+topical 5% minoxidil tincture), leptin group (testosterone propionate+restructuring mice leptin). The ratio of the number of hair follicles in the growing period to the number of hair follicles in the resting period (A/T) was assessed. The proliferation and apoptosis and androgen receptor protein content in alopecia was detected. Results: (1) The area of hair loss in the minoxidil group and leptin group was smaller than that in the model group. (2) Compared to the model group, the A/T score and Ki67 level in the minoxidil group and leptin group were significantly higher (Ps<0.05), and there was no significant statistical difference between minoxidil group and leptin group (Ps> 0.05). (3) There were no statistically significant difference in apoptotic expression and AR receptor level between the minoxidil group and leptin group (Ps>0.05). Conclusion: Subcutaneous injection of leptin is effective on androgenetic alopecia mice model, and the effect is equivalent to topical 5% minoxidil solution. 

Key words: leptin, androgenetic alopecia, proliferation, apoptosis, androgen receptors